Market Size of Single-use Bioprocessing Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
CAGR | 11.50 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Single-use Bioprocessing Market Analysis
The single-use bioprocessing market is anticipated to register a CAGR of 11.5% during the forecast period.
The initial phase of the pandemic substantially impacted the growth of the single-use bioprocessing market owing to the significant decline in manufacturing processes and restricted demand and supply of drugs. However, single-use technology (SUT) became a leading technology in pre-commercial manufacturing, including preclinical and clinical scales. With the increasing number of COVID-19 cases, the demand for effective drugs and many vaccines increased. It also increased the adoption of biopharmaceutical companies' single-use bioprocessing systems and technology due to fewer chances of contamination and reduced sterilization tests between the batches. Also, drug discovery using single-use technologies became a major focus for managing the pandemic. For instance, according to an article published in the National Library of Medicine in November 2022, it was observed that the pandemic accelerated the growing demand for single-use devices for the rapid production of drugs and vaccines. Due to the increased infection rates, most COVID-19 vaccine research is based on single-use technologies. Thus, these efforts involve using novel approaches, such as mRNA and DNA technologies. Hence, the studied market witnessed significant growth during the COVID-19 pandemic.
Factors such as faster implementation and lower risk of product cross-contamination, increasing demand for biopharmaceuticals, lower costs, and lesser environmental impact of single-use bioprocessing technologies are expected to boost the market growth.
The demand for biopharmaceuticals increased due to the high population suffering from chronic diseases. It raises the need for effective drugs and products for their treatment, which is anticipated to fuel the demand for single-use technologies and related products, thereby propelling market growth. For instance, according to the data published by the FDA, in February 2023, about 14 biologics were approved for treating various chronic diseases in 2022. The pharmaceutical industry is expected to increase the utilization and adoption of single-use bioprocessing technologies and systems over the forecast period.
The ability to deploy single-use monitoring tools and improvements in sensing technologies allow producers more control over their processes, which increases their adoption. Also, adopting single-use technologies and systems helps biopharmaceutical companies overcome the challenges of eradicating contamination risks, thus lowering the need for sterilization between batches and increasing productivity. In addition, single-use bioreactors and fermentors provide high flexibility, making it easier to experiment with various designs to optimize the process. The system offers reduced energy consumption, water consumption, and the plant's environmental footprint over conventional bioprocessing systems. It makes them a preferred choice across the pharmaceutical industry. Also, the increasing focus of the companies on developing a new single-use system that is utilized in both upstream and downstream processing of the production of biopharmaceuticals is expected to fuel market growth.
Furthermore, adopting big data-based machine learning in single-use systems increases the product or drug yield while achieving maximum productivity and efficiency in terms of process, and the use of mainstream strategy by many biopharmaceutical manufacturers is also contributing to the market growth.
Moreover, the rising adoption of various business strategies such as collaborations, partnerships, new product launches, and other company initiatives are also expected to propel the market growth. For instance, in May 2021, Qosina entered into a distribution agreement with Nordson MEDICAL to support Single-Use Bioprocess Integrators and Medical Device Manufacturers. Also, in March 2021, Thermo Fisher launched 3,000 and 5,000 L HyPerforma DynaDrive Single-use Bioreactors. These bioreactors offer features that support cell culture performance across scales, accommodate high-density and next-generation cell culture processes, and reduce overall costs through reduced capital investment, operational expenses, and higher-output processes. DynaDrive S.U.B.s also provide superior turn-down in stirred tank reactors, which lowers the number of vessels needed for seed-train scale-up. The new systems offer increased scalability, improved turn-down ratio, and improved mixing.
Therefore, owing to the factors above, such as the high demand for biopharmaceutical products, several advantages offered by single-use systems, and the increasing company activities, the studied market is anticipated to grow over the forecast period. However, the issues related to leachable and extractable are likely to restrain the market growth over the forecast period.
Single-use Bioprocessing Industry Segmentation
As per the scope of the report, single-use bioprocessing is a fast-moving technology used to develop disposable bioprocessing equipment to manufacture biopharmaceutical products. The Single-use Bioprocessing Market is segmented by product (filtration assemblies, media bags and containers, disposable/single-use bioreactors, disposable mixers, and other products), application (filtration, cell culture, purification, and other applications), end user (biopharmaceutical manufacturers, academic, and clinical research institutes, and other end users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.
By Product | |
Filtration Assemblies | |
Media Bags and Containers | |
Disposable/Single-use Bioreactors | |
Disposable Mixers | |
Other Products |
By Application | |
Filtration | |
Cell Culture | |
Purification | |
Other Applications |
By End User | |
Biopharmaceutical Manufacturers | |
Academic and Clinical Research Institutes | |
Other End Users |
By Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Single-use Bioprocessing Market Size Summary
The single-use bioprocessing market is poised for significant growth, driven by the increasing adoption of single-use technologies in the biopharmaceutical sector. Initially impacted by the pandemic, the market rebounded as single-use technology became essential for pre-commercial manufacturing, particularly in the rapid development of COVID-19 vaccines and treatments. The advantages of single-use systems, such as reduced contamination risks, lower sterilization requirements, and cost-effectiveness, have made them a preferred choice in the industry. The rising demand for biopharmaceuticals, fueled by chronic disease prevalence, further propels the market, as companies seek efficient and scalable solutions to meet therapeutic needs. The integration of advanced monitoring and sensing technologies enhances process control, contributing to the broader adoption of single-use systems.
North America is expected to maintain a significant market share, supported by robust research and development activities, a strong manufacturing presence, and substantial government investments in biopharmaceutical capacity. The region's well-established healthcare infrastructure and increasing healthcare expenditure further bolster market growth. Companies are actively expanding their single-use bioprocessing capabilities through strategic collaborations, new product launches, and the establishment of dedicated facilities. Despite challenges related to leachables and extractables, the market's growth trajectory is supported by the ongoing development of innovative single-use systems and the rising focus on sustainability and efficiency in biopharmaceutical manufacturing.
Single-use Bioprocessing Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Faster Implementation and Lower Risk of Product Cross-contamination
-
1.2.2 Increasing Demand for Biopharmaceuticals
-
1.2.3 Lower Costs and Lesser Environmental Impact of Single-use Bioprocessing Technologies
-
-
1.3 Market Restraints
-
1.3.1 Issues Related to Leachables and Extractables
-
-
1.4 Industry Attractiveness - Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Suppliers
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value in USD)
-
2.1 By Product
-
2.1.1 Filtration Assemblies
-
2.1.2 Media Bags and Containers
-
2.1.3 Disposable/Single-use Bioreactors
-
2.1.4 Disposable Mixers
-
2.1.5 Other Products
-
-
2.2 By Application
-
2.2.1 Filtration
-
2.2.2 Cell Culture
-
2.2.3 Purification
-
2.2.4 Other Applications
-
-
2.3 By End User
-
2.3.1 Biopharmaceutical Manufacturers
-
2.3.2 Academic and Clinical Research Institutes
-
2.3.3 Other End Users
-
-
2.4 By Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia Pacific
-
-
2.4.4 Middle East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Single-use Bioprocessing Market Size FAQs
What is the current Global Single-use Bioprocessing Market size?
The Global Single-use Bioprocessing Market is projected to register a CAGR of 11.5% during the forecast period (2024-2029)
Who are the key players in Global Single-use Bioprocessing Market?
Sartorius AG, Thermo Fisher Scientific, Eppendorf AG, Merck KGaA and Danaher Corporation (Cytiva) are the major companies operating in the Global Single-use Bioprocessing Market.